What Ginemed does

Ginemed is a Spanish private healthcare group specializing in assisted human reproduction, founded in 1992 in Sevilla. It operates 13 clinic locations across Spain (Sevilla as headquarters with a High Complexity Cases Center; Madrid Centro, Madrid Aravaca, Barcelona, Bilbao, Valencia, Huelva, Jerez, San Fernando, Málaga, and Asturias) and Portugal (Lisboa and Oporto), with several units co-located inside hospital networks operated by Quirónsalud and Vithas. The company's clinical portfolio spans the full fertility treatment lifecycle — artificial insemination, IVF, ICSI, egg donation, double donation, ROPA method for female same-sex couples, embryo donation, and fertility preservation — supported by complementary laboratory techniques (PGT, MACS sperm selection, Genetic Compatibility Testing, Sperm Fragmentation Test, Geri time-lapse embryo monitoring, Fertile Chip) and a proprietary Matcher electronic witnessing system for patient/sample traceability. Ginemed also operates specialized units for high-complexity cases including implantation failure/recurrent miscarriage, advanced maternal age, endometriosis, PCOS, and male factor infertility.

The business model is fee-for-service consumer healthcare: per-treatment-cycle pricing for fertility procedures, with a free first consultation as the top-of-funnel conversion mechanism. Treatment tickets are financed through a partnership with Sabadell Consumer Finance SAU at 0% interest over 6-24 months (minimum €5,500 for the 24-month tier), with fertility study packs offered free to patients who initiate treatment. Revenue diversification extends to international medical tourism, supported by an International Department with native-speaking coordinators in 8 languages (Spanish, Portuguese, English, Italian, French, Arabic, German, Russian, Chinese) and country-specific localized websites. The Ginemed Maternity guarantee program — pregnancy until birth or money back, covering both own-egg and donor-egg cycles — is a distinctive commercial differentiator in the Spanish market. Disclosed clinical outcomes include a 73% IVF-ICSI pregnancy rate with two blastocysts transferred and 71% natural cycle IVF rate (2020 results), with over 50% of patients achieving pregnancy on first attempt.

Ginemed is positioned as a 30+ year reference center in the Iberian fertility market, anchored by multiple regulatory credentials (ISO 9001 since 2004, AENOR 2022, Spanish Ministry of Health authorization, Sociedad Española de Fertilidad accreditation, IDIS affiliation) and university research partnerships with seven Spanish institutions, including a Master Program in Human Assisted Reproduction with the University of Sevilla. The group reports 101-250 employees, is privately held with no disclosed ownership structure, investors, or M&A history, and has no disclosed revenue figures. No AI/ML capabilities, patents, or API/integration surfaces are evidenced in the source data.

Name

Ginemed

Legal name

Ginemed

Website

https://ginemed.es

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

101–250 employees

Short description

Ginemed is a Spanish private healthcare group founded in 1992, operating 13 fertility clinics across Spain and Portugal. It provides the full range of assisted reproduction treatments — IVF, ICSI, egg/embryo donation, ROPA method, fertility preservation — plus high-complexity specialty units and an international patient program in 8 languages.

Ownership category

akta.pro rank

Product category

Reproductive Health Services

NAICS

Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Fertility/IVF & Reproductive Tourism Agencies (THAKAIAF), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)

Keywords

• Assisted reproduction services
• Fertility treatments
• IVF services
• Fertility clinics
• Reproductive medicine

Headquarters

HQ city

Sevilla

HQ country

Spain

HQ region

Europe

Offices12 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Assisted Reproduction Treatments: Fee-for-service medical treatments including artificial insemination, IVF, egg donation, double donation, ROPA method, embryo donation, and fertility preservation. Revenue generated per treatment cycle performed.
2. Financing Plans: Partnership with Sabadell Consumer Finance SAU offering 0% interest financing for 6, 12, 18, and 24 months. Minimum financing amount of 200 euros, with 24-month option requiring minimum 5,500 euros.
3. Fertility Study Packs: Diagnostic fertility testing packages included free when patient initiates treatment, otherwise sold as standalone diagnostic services.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Ginemed is a healthcare provider specializing in assisted reproduction (fertility) treatments, founded in 1992 in Sevilla, Spain. The company operates a network of 13 fertility clinics across Spain and Portugal, delivering services such as in vitro fertilization (IVF), artificial insemination, egg donation, and other specialized reproductive medicine procedures to individuals and couples seeking fertility care.

Product overview

Ginemed is a healthcare group specializing in Assisted Reproduction operating as a unified clinic network rather than a modular platform. The company offers a comprehensive portfolio of fertility treatments centered around core procedures including Artificial Insemination (IA), In Vitro Fertilization (FIV-ICSI), Egg Donation (Ovodonación), Double Donation, ROPA Method, Embryo Donation, and Fertility Preservation. These core treatments are supported by complementary laboratory techniques such as ICSI, MACS sperm selection, Genetic Compatibility Testing (Matching), Sperm Fragmentation Testing, Preimplantation Genetic Testing (PGT), Time-lapse Geri embryo culture, and Fertile Chip. Ginemed also provides specialized units for complex cases including Implantation Failure and Recurrent Miscarriage, Advanced Maternal Age, Male Factor, Reproductive Endocrinology, Endometriosis, and Polycystic Ovary Syndrome. The company differentiates through proprietary technology systems like Matcher (electronic witnessing for patient/sample traceability) and programs like Ginemed Maternity (pregnancy guarantee). Additional services include fertility testing packages and financing plans. Founded in 1992, the company operates clinics across Spain and Portugal.

Differentiator

Problem solved

Functional benefit

Brands

• Ginemed Maternity: Pregnancy guarantee program that ensures pregnancy until birth or money back guarantee with own and donated eggs.

Products and services

• In Vitro Fertilization (IVF) Assisted reproduction procedure in which eggs are fertilized by sperm outside the body and the resulting embryo is transferred to the uterus; offered to individuals and couples facing infertility.
• Artificial Insemination Fertility treatment in which sperm is placed directly into the uterus or cervix to facilitate fertilization; offered to individuals and couples seeking fertility assistance.
• Egg Donation Program Donor-egg-based fertility treatment enabling patients with diminished ovarian reserve or other indications to achieve pregnancy using eggs from a screened donor.
• Specialized Reproductive Medicine Services Additional specialized fertility diagnostics and treatments delivered across Ginemed's network of clinics in Spain and Portugal.

Quantifiable outcome

• 73% pregnancy rate with 2 embryos transferred on day +5 (IVF-ICSI)
• +3 more outcomes

Segments6 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Universidad de SevillacoreStrategic or Co-development PartnerUniversity collaboration for research and education in human reproduction. Ginemed participates in the Master's Program in Assisted Human Reproduction.
• Universidad de HuelvaminorStrategic or Co-development PartnerUniversity collaboration for academic and research purposes.
• Universidad de MálagaminorStrategic or Co-development PartnerUniversity collaboration for academic and research purposes.
• Universitat de ValènciaminorStrategic or Co-development PartnerUniversity collaboration for academic and research purposes.
• Universidad de MurciaminorStrategic or Co-development PartnerUniversity collaboration for academic and research purposes.
• Universidad de OviedominorStrategic or Co-development PartnerUniversity collaboration for academic and research purposes.
• Universidad Rey Juan CarlosminorStrategic or Co-development PartnerUniversity collaboration for academic and research purposes.

Scale indicators8 records

Recent moves20 records

Expansion highlights6 records

Direct peers

• Clínica Tambre: Tambre is a long-established Madrid fertility clinic offering IVF, ICSI, egg donation, and shared motherhood (ROPA), directly competing with Ginemed's Madrid Centro and Aravaca centers for patients in the Spanish capital.
• IVI-RMA Global: IVI-RMA Global is the largest assisted reproduction group in Spain and a global IVF leader, operating a multi-country clinic network that directly competes with Ginemed across IVF, ICSI, egg donation, and fertility preservation.
• Procreatec: Procreatec is a Madrid-based assisted reproduction clinic offering IVF, PGT, and ROPA method, directly competing with Ginemed for patients in the Madrid region and across Spain.
• Ovoclinic Madrid: Ovoclinic is a Spanish fertility network with multiple clinics and a focus on personalized IVF cycles, donor programs, and international patient acquisition — directly comparable to Ginemed's clinic-and-international model.
• CEFER (Centro de Fertilidad): CEFER is a fertility clinic group with operations across several Spanish regions, providing IVF and donor treatments comparable to Ginemed's core offering.
• Vida Fertility: Vida Fertility is a Spanish fertility clinic group with clinics in Madrid, Alicante, and other regions, providing IVF, ICSI, and donor services; it competes with Ginemed across overlapping Spanish geographies and patient segments.
• Eugin (now part of IVI-RMA): Eugin is a Barcelona-headquartered fertility group with clinics in Spain and internationally, focused on IVF and donor programs; it is a direct competitor to Ginemed's core service line and overlapping Iberian footprint.

Broad incumbents

• Quirónsalud: Quirónsalud is Spain's largest private hospital group, which co-hosts several Ginemed units (Huelva, Bilbao) and also operates its own reproductive medicine services as part of its broader hospital portfolio.
• Vithas Hospitals: Vithas is a Spanish private hospital group that hosts Ginemed units in Valencia and Madrid Aravaca and also offers its own fertility services, positioning it as both a partner and partial competitor to Ginemed.

Regional players

• ReproMed Portugal: ReproMed is a Portuguese fertility clinic group offering IVF and reproductive medicine services, competing with Ginemed's Lisbon and Porto units in the Portuguese market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/GinemedC
• Facebookfacebook.com/GinemedClinicas

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ginemed